Cargando…
Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in Alberta, Canada: A real‐world evidence study
BACKGROUND: Atherosclerotic cardiovascular disease (ASCVD) is a leading cause of morbidity and mortality worldwide. Data from Canadian populations regarding the burden of ASCVD are limited. Therefore, we describe the 5‐year period prevalence of ASCVD and subsequent major adverse cardiovascular event...
Autores principales: | Chen, Guanmin, Farris, Megan S., Cowling, Tara, Pinto, Lionel, Rogoza, Raina M., MacKinnon, Erin, Champsi, Salimah, Anderson, Todd J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571560/ https://www.ncbi.nlm.nih.gov/pubmed/34585767 http://dx.doi.org/10.1002/clc.23732 |
Ejemplares similares
-
Cost-Effectiveness Analysis of Evolocumab in Adult Patients with Atherosclerotic Cardiovascular Disease in Canada
por: Grégoire, Jean, et al.
Publicado: (2022) -
Increasing Prevalence and Incidence of Atherosclerotic Cardiovascular Disease in Adult Patients in Ontario, Canada From 2002 to 2018
por: Mackinnon, Erin S., et al.
Publicado: (2021) -
Correction to: Guideline LDL-C Threshold Achievement in Acute Myocardial Infarction Patients: A Real-World Evidence Study Demonstrating the Impact of Treatment Intensification with PCSK9i
por: Mackinnon, Erin S., et al.
Publicado: (2023) -
Guideline LDL-C Threshold Achievement in Acute Myocardial Infarction Patients: A Real-World Evidence Study Demonstrating the Impact of Treatment Intensification with PCSK9i
por: Mackinnon, Erin S., et al.
Publicado: (2023) -
Impacts of Alternative Billing Claims on Hypertension Prevalence and Mortality Estimates in Alberta, Canada
por: Cunningham, Ceara Tess, et al.
Publicado: (2017)